Abstract
Atrial fibrillation (AF) remains a widespread health problem and the drugs available for its treatment suffer from several drawbacks, including potentially lethal proarrhythmia, serious non-cardiac toxicity and limited efficacy. The evidence for efficacy of currently available anti-arrhythmic agents for sinus rhythm restoration and maintenance is reviewed, with emphasis on randomised trials when available. The current approach to thromboembolism prophylaxis in AF is summarised. 1999
| Original language | English (US) |
|---|---|
| Pages (from-to) | 81-96 |
| Number of pages | 16 |
| Journal | Expert Opinion on Pharmacotherapy |
| Volume | 1 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1999 |
Keywords
- Anti-arrhythmic drugs
- Anticoagiilation
- Atrial fibrillation
- Thromboembolism
- Treatment
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)